ORIC Pharmaceuticals Inc. (ORIC) Appoints Steven L. Hoerter to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to ORIC Pharmaceuticals Inc. (ORIC) Appoints Steven L. Hoerter to its Board

ORIC Pharmaceuticals Appoints Steven L. Hoerter to its Board of Directors

August 16, 2021 4:15 PM EDT

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced the appointment of 25-year industry veteran Steven L. Hoerter to its Board of Directors.

We are thrilled to welcome Steve to ORICs board of directors, said Jacob Chacko, M.D., president and chief executive officer. Over a multi-decade career spanning executive roles in sales, marketing, commercial, and public company leadership, Steve has amassed deep experience at leading oncology... More